Metraipolis › archive › dc_657f8d6d7463
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old — Europe PMC PMID:41560517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41560517
- DOI
- 10.1093/cid/ciag026
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T23:46:14.369Z
- SHA-256 of the archived text
8f37d28c853f707cd04af2cd0e8a5f123de8ac0ff817b6c375e9d1aa4436a8a0- Stable URL of this page
https://metraipolis.com/documento/dc_657f8d6d7463
How to cite
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old — Europe PMC PMID:41560517 — Europe PMC (en), https://europepmc.org/article/MED/41560517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_657f8d6d7463 (Metraipolis archive dc_657f8d6d7463, sha256 8f37d28c853f707cd04af2cd0e8a5f123de8ac0ff817b6c375e9d1aa4436a8a0)
BibTeX
@misc{dc657f8d6d7463,
title = {Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old — Europe PMC PMID:41560517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41560517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_657f8d6d7463; sha256 8f37d28c853f707cd04af2cd0e8a5f123de8ac0ff817b6c375e9d1aa4436a8a0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41560517. Agents can read the archived copy with the MCP tool read_document.